.svg){kind=small}
Jan-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Stigma Grow has demonstrated a consistent performance in the Alberta market, particularly in the Capsules category. Over the four-month period from October 2024 to January 2025, the brand maintained a stable ranking, climbing from 4th to 3rd place, which indicates a strong foothold in this category. This upward trend is further supported by a steady increase in sales figures, culminating in a notable January 2025 performance. In contrast, the Concentrates category in Alberta showed more fluctuation, with rankings oscillating between 12th and 17th place. Despite this variability, the brand achieved significant sales growth in January, suggesting potential for future improvement in this category.
In British Columbia, Stigma Grow's performance in the Capsules category remains relatively stable, maintaining a position within the top 10, though it did experience a slight dip in December 2024. The brand's sales in this category have shown resilience, bouncing back in January 2025. However, in the Concentrates category, Stigma Grow did not manage to break into the top 30 in Ontario, which could indicate a challenging market environment or stronger competition. The brand's performance in the Capsules category in Ontario is more promising, consistently holding a top 10 rank, reflecting a more robust market presence there.
Competitive Landscape
In the competitive landscape of the capsules category in Alberta, Stigma Grow has maintained a steady presence, consistently ranking third from November 2024 to January 2025. This stability in rank suggests a solid market position, although it trails behind top competitors like Glacial Gold and Tweed, which have consistently held the first and second ranks, respectively. Despite this, Stigma Grow has shown a positive trend in sales, increasing from October 2024 to January 2025, which indicates a growing consumer base and potential for further market penetration. Meanwhile, Emprise Canada has shown notable improvement, jumping from seventh to fourth place by January 2025, which could pose a future threat to Stigma Grow's position if this upward trend continues. Overall, while Stigma Grow is currently stable, the dynamic shifts among competitors highlight the importance of strategic marketing and product differentiation to maintain and improve its standing in the Alberta market.
Notable Products
In January 2025, the top-performing product from Stigma Grow was the Indica RSO Capsules 25-Pack (250mg) in the Capsules category, maintaining its number one rank for four consecutive months with sales reaching 6,355 units. The Phoenix Tears RSO (1g) from the Concentrates category also held steady at the second rank, showing consistent popularity with 4,327 units sold. The CBD Softgels 15-Pack (750mg CBD) continued to rank third, reflecting stable demand in the Capsules category. Phoenix Tears Resin (1g) and Phoenix Tears Honey Oil (1g) remained in fourth and fifth positions respectively, indicating a steady trend in consumer preferences for these Concentrates. Overall, the rankings of these top products have remained unchanged since October 2024, suggesting a strong and consistent market performance for Stigma Grow's offerings.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
